The AKT protein is frequently deregulated in a variety of human cancers, leading to overactivation and promotion of tumor cell survival, proliferation, migration, metabolism, angiogenesis, and radiochemotherapy resistance by regulating the function of multiple downstream molecules (29–31). The gene discussed is AKT1; the disease is cancer.